I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| naive B cell | 10 studies | 20% ± 5% | |
| B cell | 9 studies | 21% ± 3% | |
| natural killer cell | 7 studies | 20% ± 4% | |
| plasmacytoid dendritic cell | 7 studies | 23% ± 8% | |
| non-classical monocyte | 5 studies | 26% ± 7% | |
| CD4-positive, alpha-beta T cell | 5 studies | 19% ± 3% | |
| memory B cell | 5 studies | 17% ± 1% | |
| classical monocyte | 4 studies | 22% ± 4% | |
| smooth muscle cell | 4 studies | 18% ± 5% | |
| epithelial cell | 4 studies | 36% ± 15% | |
| endothelial cell | 4 studies | 23% ± 6% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 19% ± 2% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| precursor B cell | 3 studies | 22% ± 5% | |
| fibroblast | 3 studies | 17% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 19% ± 1% | |
| dendritic cell | 3 studies | 34% ± 8% | |
| pericyte | 3 studies | 20% ± 3% |
